Evidence-backed European AI register
LynxCare
Reviewed identity, roles, model listings, pricing and evidence for LynxCare.
Dataset compiled 2026-08-28 · evidence over inference
Reviewed identity
- Headquarters scope
- headquarters unknown
- Headquarters country
- unknown
- Headquarters city
- unknown
- Legal entity
- Belgian company
- Ownership
- VC-backed private; PMV (Flemish regional investment company) among backers
- Founded
- 2015
- Confidence
- medium
- Last verified
- 2026-08-22
Headquarters evidence
No qualifying headquarters passage was promoted.
Reviewed sources discuss Leuven operations and company facts, but no qualifying headquarters wording was found.
Evidence boundaries
Organisation listings identify a reviewed canonical record. Headquarters is independent of incorporation, registered offices, ownership, hosting and runtime. Model listings show an association in the source register; they do not by themselves establish model creation, current API availability, hosting location or infrastructure ownership.
Model listings
- LynxCare clinical NLP pipelines
- Type
- text
- Parameters
- unknown
- Context
- unknown
- Languages
- multiple European clinical languages (Dutch, French and others); exact list not verified
- Licence
- proprietary
- Release
- unknown
Profile note
Leuven clinical-NLP company running healthcare-trained pipelines over unstructured clinical text to extract, contextualise and normalise medical entities (diagnoses, symptoms, procedures, medications, outcomes) and combine them with structured EHR data. Domain-specific European-language clinical NLP is a genuine gap that US general-purpose LLMs handle poorly. The €20M Series A was reported as being raised (Feb 2026) rather than closed — treat as unconfirmed.